Site Search
Site Search
A large study, part-funded by the Innovative Medicines Initiative (IMI) through the DIRECT, SUMMIT and BEAT-DKD projects, identified a protein in the blood that could predict type...
IHI call 12, which is scheduled for launch in early 2026, will invite applicants to explore new opportunities for IHI projects in the IHI Strategic Research and Innovation Agenda.
Scientists in PD-MitoQUANT are studying how breakdown in cells’ mitochondrial function is implicated in Parkinson’s disease. Tools developed by SME geneXplain are helping them do...
While previous IHI calls defined the challenges applicants should address, call 9 will invite applicants to identify untapped opportunities in the IHI Strategic Research and...
A wide-ranging evaluation of IMI2 and IHI highlights the ability of the programmes to drive innovation and have an impact on patient care and quality of life.